Skip to content

Effectiveness of homoeopathic medications in cases of urinary tract infections

Role of individualised homoeopathic medicine in urinary tract infections - an in-vitro and pre-post, single arm clinical trial - nil

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080658
Enrollment
40
Registered
2025-02-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

Intervention1: Individualised homoeopathic medicines: Using the eligibility criteria and obtaining written informed consent participants will be included in the study. Patients will be administered in

Sponsors

National Institute of Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having two or three UTIs in six months or three or more in a year or if symptoms that don t disappear within 24 to 48 hours after treatment begins or if urinary tract infection that lasts longer than two weeks Patients of both genders different socio economic status of all religions Patients of age groups 10 to 60 years of age Patient s parents who are willing to give written informed consent and to participate in the study and give verbal children aged between 10 to 11 years and or written assent children aged between 12 to 17 years Patients or parents or guardians of patients who can read or write or understand either English Hindi or Bengali languages

Exclusion criteria

Exclusion criteria: Pregnant or lactating women Patient taking any antibiotics Patients undergoing any other homeopathic medications Patient having any psychiatric or life threatening illness severe systemic illness or immuno compromised state Patients with any conditions requiring surgical interventions such as SOL malignancy or stone in PUJ or VUJ

Design outcomes

Primary

MeasureTime frame
Determination of the invitro effectiveness of the individualised homoeopathic medicines against inhibiting growth of the bacterial pathogens causing chronic urinary tract infections Significant changes of UTI SIQ 8 score before and after treatment with individualised homoeopathic medicines for patients affected by chronic urinary tract infectionTimepoint: Baseline 3 and 6 months

Secondary

MeasureTime frame
Determination of any correlation between clinical study and invitro bacterial inhibitionTimepoint: Baseline 3 and 6 months

Countries

India

Contacts

Public ContactDr Pratima Pal

National Institute of Homoeopathy

ezhilmathishanmugam37@gmail.com9688907467

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026